What is the market doing?
What the tape says about ORKA
Oruka Therapeutics, Inc. is +519% over the past year while the S&P 500 is +20%: 499 points ahead of the market.
+519%
1-year return · S&P 500 +20%
- vs 200-day average
- +73%
vs 200-day average · a clear uptrend
- RSI (14)
- 24
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 16%
Below its 52-week high
Details›
- Last close2026-09-08
- $94.41
- 1 monthS&P 500 −0.30%
- −4.0%
- 1 yearS&P 500 +20%
- +519%
- 5 yearsS&P 500 +85%
- +381%
- vs 50-day average$91.46
- +3.2%
- 52-week high
- $113.05
- 52-week low
- $14.40
- Annualised volatility
- 83%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$356K
| Year | Return |
|---|---|
| 2026 (year to date) | +211% |
| 2025 | +56% |
| 2024 | +77% |
| 2023 | −28% |
| 2022 | +10% |
| 2021 | −46% |
| 2020 | −30% |
| 2019 | −3.9% |
| 2018 | −76% |
| 2017 | −53% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | −0.45% |
| Feb | 10 | 5 of 10 | −8.4% |
| Mar | 10 | 4 of 10 | −4.4% |
| Apr | 10 | 8 of 10 | +15% |
| May | 10 | 8 of 10 | +26% |
| Jun | 10 | 5 of 10 | +3.3% |
| Jul | 11 | 6 of 11 | +2.2% |
| Aug | 11 | 4 of 11 | −5.4% |
| Sep | 11 | 3 of 11 | −2.8% |
| Oct | 10 | 5 of 10 | +3.1% |
| Nov | 10 | 6 of 10 | −1.6% |
| Dec | 10 | 5 of 10 | −2.7% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.